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ABSTRACT 
Objective: Osteoporosis and associated fractures are an important cause of mortality and morbidity. The aim of the study is to evaluate the effects 
of different treatment modalities calcium, calcium+VitD3 and calcium+physiotherapy and finds their effects on the quality of life in osteoporotic 
patients using International Osteoporosis Foundation Qualeffo-41Questionnaire and calculates the prevalence in the study sites. 
Methods: An open, randomized study comparing the effect of three treatment modalities was carried out in 100 patients (expecting 20%drop out) 
for six months between September 2013 and March 2014. 
Results: On the evaluation of 82 patients for 6 mo it showed that prevalence of osteoporosis is 4.82% in Nilgiris district, TamilNadu. Among the 
different domains of QUALEFFO-41questionnaire of osteoporotic international foundation (IOF), patients treated with calcium were effective in 
improving leisure, social activity (at P<0.01). Calcium &physiotherapy was found to be effective in improving mobility and pain (at P<0.0001). But 
Calcium & Vitamin D3 group proved to be effective in improving Physical function like activities of daily living (at P<0.001). 
Conclusion: Osteoporotic population taking calcium along with physiotherapy showed an improvement in the total quality of life. 
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INTRODUCTION 
Osteoporosis is a disease in which bones become fragile and weak; 
leading to an increased risk of fractures. Osteoporosis has no signs 
or symptoms until a fracture occurs this is why it is s called a ‘silent 
disease’ [1]. It occurs in approximately, one-fourth of all elderly 
persons and most commonly in women between 50 and 70 y old. 
Epidemiologic data revealed that its prevalence increases with age, 
and it is particularly common in postmenopausal women. With 
increasing longevity of the Indian population, it is now being 
realized that, as in the West, osteoporotic fractures are a major 
cause of morbidity and mortality in the elderly in our nation [2]. As 
it is not a benign disease it has an impact on mortality, quality of life, 
the burden on the family, costs to the health care system and it will 
cause repeated fracture in people thus this condition worsen the life 
of the world population. Thus, it is important that treatment goals 
should not be directed towards improving physiological end point 
but also patient’s physical and mental health (i.e. Quality of life with 
the overall goal of reducing the debilitating impact of osteoporosis 
on patient’s lives)[3]. Generic health-related quality of life 
instrument used in osteoporosis is International Osteoporosis 
Foundation Qualeffo-41Quality of Life Questionnaire. The study is 
focused on finding the prevalence and the effect of three different 
treatment lines, (calcium, calcium+vitamin D3 & calcium+ 
physiotherapy) on total quality of life in osteoporotic population of 
Nilgiris district using Qualeffo-41 Questionnaire [4]. 
MATERIALS AND METHODS  
The study started with the preparation of the study protocol by a 
systematic literature survey, a protocol was prepared and was 
approved by the intuitional review board JSSCP/DPP/ IRB/018/ 
2013-14 of J. S. S College of Pharmacy, Udhagamandalam, Tamil 
Nadu, India. The study sites were identified as Government 
Headquarters Hospital, Ooty and the private orthopedics clinics in 
Ooty. The data collection form was prepared to collect the necessary 
data from the patients. IOF QUALLEFFO-41 questionnaire was used 
to assess the quality of life of patients enrolled in the study. The 
validation of the Qualeffo-41 Questionnaire for internal consistency 
was done using SPSS v17, the values of Cronbach’s alpha is 0.78 
considered that the questionnaire has internal consistency. The 
patients informed consent form and the data collection form was 
prepared in both English and Tamil. The study design was an open 
label, pilot, randomized study, which was scheduled for a period of 
6months with a total sample size of 100 patients (expecting 20% 
drop out). The study accepts no healthy volunteers within the age 
groups of 18 to 80 y and both the genders. The inclusion criteria 
included patients with age 18 and above, both smokers and 
nonsmokers, both alcoholics and non-alcoholics and subjects with 
exercising and non-exercising habits, the exclusion criteria included 
pregnancy and lactating women, patients with psychiatric issues, 
patients on antiepileptics, Patients with HIV+VE, 
• Group-I: Patients with Calcium (500 mg) dose as prescribed by the 
physician. 
Thyroid patients, 
Patients with Rheumatoid Arthritis, Patients with Chronic Kidney 
Disease (CKD), Patients with Congestive cardiac failure (CCF). The 
source of data included Patient interview, Medical records and 
Laboratory data. Patient satisfying inclusion criteria after giving 
informed consent were enrolled for the study and the purpose of the 
study was explained in detail to the patient before enrollment. 
Initially, the demographic of the patient like gender, age, marital 
status, education, occupation, food habits, social habits, educational 
status, exercise, lab parameters, BMI and presence of other specific 
health problems, family history, past medication and medical history 
and current treatment were collected. Then the patients were 
allocated into groups according to the therapy:  
• Group II: Patients with Calcium (500 mg)+Physiotherapy as 
prescribed and advised by physician 
• Group III: Patients with Calcium+Vitamin D3 (Ultra-D3 25µg) dose 
as prescribed by a physician. 
After an explanation of the International Osteoporosis Foundation, 
Qualeffo-41 Questionnaire was administered to the patients and the 
answers were recorded. The first recording is considered as a 
baseline (V0) and the follow-up was done at mid visit i.e., V3 and at 
last visit i.e., V6. Each follow-up was done at 30 d intervals between 
each visit. The blood samples were collected from the patient at 
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baseline (V0), mid visit (V3) and end of the study (V6) for analysis 
serum calcium. The patients were provided with leaflet both in 
English and Tamil for better understanding of the disease. The 
counseling was provided to the patients during all their follow up 
visits (V0 to V6). The obtain data was entered to Microsoft Excel 
sheet, mean and standard deviation were calculated. The obtained 
values of standard deviation and mean were incorporated into 
statistical software ‘Instat version 3.00’ and the significance was 
calculated by student t-test and one way ANOVA. A P value less than 
0.05 were considered as significant (P<0.05). 
 
Parameters and follow up visits 
Parameter V V0 V1 V2 V3 V4 V5 6 
Body weight (Kg)   √   √   √ 
Height (cm)  √   √   √ 
BMI  √   √   √ 
 ALP  #       
CBC  #       
SERUM CALCIUM LEVELS  √   √   √ 
LFT  #       
Counseling  √ √ √ √ √ √ √ 
# Represents tests done before the subject enrollment 
 
RESULTS 
Table 1 shows that 80.48% of the sample was female. About half of 
the samples were aged above 60 (53.65%). In relation to their habit, 
87.80% were nonsmokers; about54.87% has no exercise habit. In 
the context of their dietary habit, about three-quarters of the 
population enrolled in the study was non-vegetarian 76.82%. 
Regarding their educational status, 68.29% was literate, and 
majorities were married 93.30 %. 
Regarding the effect of calcium alone in osteoporotic patients on 
various domains like pain, activities of daily living, jobs around the 
house, mobility, leisure, social activities, general health perception 
and mental function are represented in table 2. From this study, a 
slight improvement in physical function (leisure, social activities) 
was observed in this treatment group (P<0.01). No significance 
change was found in other domains like pain, physical function 
(activities of daily living, mobility, general health perception, mental 
function and jobs around the house) in Qualeffo-41Questionnnarie 
of international osteoporosis foundation. 
As regards calcium+physiotherapy, the result indicates that a 
significant change on different domains in osteoporosis patients 
with Qualeffo-41Questionarrie was tabulated in table 3. There was a 
significant decrease in the mean pain score after three months and 
six months of therapy (P<0.001) when compared with the basal 
score. A similar effect was also observed in physical function 
(mobility7.53±7.24 and 9.92±2.57) at mid and final visits 
respectively. Similarly, a significant improvement in physical 
function (jobs around the house and leisure, social activities) were 
found. A slight improvement in physical function (activities of daily 
living) after 3 mo of therapy was observed. In mental function, 
calcium+physiotherapy showed a decrease in the mental function 
when compared to the baseline and the end of the therapy. 
Table 4 shows about the effect of calcium+vitamin D3 on various 
domains in International Osteoporosis Foundation Qualeffo-
41Questionarrie. A significant change was observed in domains like 
activities of daily living, (17.03±12.67 at P<0.001) and jobs around the 
house (23.4±13.35at P<0.01), when compared between baseline (v0) 
and six months of treatment (v6), were as leisure, social activities, 
mental function, mobility, pain and general health perception showed 
no significant change in this treatment modality. 
Concerning total quality of life, table 5 indicates that among three 
different treatment modalities like Calcium, Calcium+physiotherapy and 
calcium+vitamin D3, patient who were on treatment with calcium+ 
physiotherapy (P<0.0001) were showing a significant improvement in 
total quality of life when compared with other treatment group, like 
calcium(P<0.7484) and calcium+vitamin D3(P<0.3588). 
Considering the average serum calcium levels of the population 
enrolled in each treatment group like calcium alone at the baseline 
visit (v0) and at end visit (v6) were 7.5 mg/dL and 8.96 mg/dL 
respectively. For calcium+vitamin D3 group showed v0 of 7.3 mg/dL 
and v6 of 9.02 mg/dL. Whereas for calcium+physiotherapy group 
showed the value of 7.56 mg/dL and 8.81 mg/dL respectively. An 
averaged BMI of the study population was found to be 22.3. 
 
Table 1: Characteristics of osteoporotic patients 















Marital status  
Married 77(93.30) 
Unmarried 5(6.09) 
Food habits  
Vegetarian 19(23.17) 
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Table 2: Effect of calcium on quality of life in osteoporotic patients 
Domain V0mean±SD (N=28) V3mean±SD (N=25) V6mean±SD (N=25) 
Pain 17.58±8.41 17.59±8.30 15.76±7.50 
Activities of daily living 21.43±11.77 22.51±11.21 22.27±9.81 
Jobs around the house 15.62±8.62 16.72±6.70 15.68±6.15 
Mobility 11.62±7.15 9.13±3.53 9.68±3.39 
Leisure, social activities 10.65±5.4 6.62±5.24 6.89±5.88## 
General health Perception 
@ 
14.48±17.88 13.96±14.42 16.10±13.58 
Mental Function 14.41±7.56 13.79±7.91 12.89±7.37 
Data expressed in mean±SD, ##: P<0.001 compared V0 and V3, @: compared V0 & V6. 
 
Table 3: Effect of calcium and physiotherapy on quality of life in osteoporotic patients 
Domain V0 mean±SD (N=25) V3 mean±SD (N=25) V6 mean±SD (N=25) 
Pain 30±20.59 7.30±7.10 12.30±7.10### @@@ 
Activities of daily living 15.38±23.53 3.07±3.96 6.76±2.94 # 
Jobs around the house 13.07±13.93 3.84±6.67  4.61±2.41## 
Mobility 
@@ 
18.92±7.98 7.53±7.24 9.92±2.57### 
Leisure, social activities 
@@@ 
14.88±5.40 20.88±9.05 ## 18.07±12.18 
General health Perception 16.53±20.33 18.46±14.88 29.16±4.25
Mental Function 
@@ 
13.84±5.89 4.56±4.56 16.76±5.33 ### 
Data expressed in mean±SD, #: P<0.01, ##: P<0.001, ###P<0.0001 compared V0 &V3, @@: P<0.001, @@@: P<0.0001 compared V0 and V6. 
 
Table 4: Effect of calcium and vitamin D3 on quality of life in osteoporotic patients 
Domain V0 mean±SD(N=29) V3 mean±SD(N=29) V6 mean±SD(N=29) 
Pain  24.66±22.77 22.96±16.73 22.63±16.58 
Activities of daily living 26.4±11.09 24.66±13.13 17.03±12.67





23.4±9.34 22.23±7.95 20.5±8.02 
Leisure, social activities 18.2±9.45 19.06±8.63 18.0±6.34 
General health Perception 27.3±19.82 24.8±20.96 23.43±21.19 
Mental Function 18.53±10.07 16.5±9.22 16.56±7.49 
Data expressed in mean±SD, @: P<0.01, @@: P<0.001compared V0 & V6. 
 
Table 5: Total quality of life (TQOL) 
Visits  V0 V3 V6 P-value 
QOL in calcium alone 54.10±6.97 55.41±5.76 55.23±7.99 P<0.7484 
 QOL in calcium and physiotherapy 47.34±5.76 35.96±6.02 26.34±5.52 P<0.0001** 
QOL in calcium and vitamin D3 51.86±7.99 51.83±7.45 49.4±6.91 P<0.3588 
Data expressed in mean±SD** P<0.0001  
 
DISCUSSION 
Osteoporosis is an important health-related problem that reduces 
the quality of life. In our present study 82 osteoporotic patients 
were enrolled according to our inclusion and exclusion criteria. They 
were categorized according to socio-demographic, lifestyle, food 
habits and medical variables. 
Out of the total population of 7, 35,394 in the Nilgiris district, 
approximately about 49,384 were found to be elderly, among the 
total elderly population a ratio of 1: 20 were found to be 
osteoporotic. This is because of various reasons such as high 
altitudes, less exposure to sunlight and poor socio-economic status.  
Of the total study population, 80.48% were females. They 
constituted two third of the study population. Females have shown 
more prevalence than males because of the hormonal changes in 
post menopause cause decrease in bone mineral density due to 
estrogen deficiency which leads to excessive bone resorption than 
bone formation [5]. 
The elderly may have the lower total quality of life for two reasons: 
either because they really do have a less varied life, because its 
seems possible that elderly people are engaging in less outside 
activities and, therefore, have less varied life. There was a 
substantial difference in activity level as a function of age. Our 
findings suggest that Quality of life judgment is based not only on 
the activities restricted but also on emotional reactions to any 
restriction [6]. 
The number of literates in the study counts over illiterates. Three-
fourth of the study patients were non–smokers 72(87.80%). A meta-
analysis of studies looking at the effect of smoking found that BMD 
in smokers was 2% lower with each increasing decade after the 
menopause than in non-smokers, with a 6% difference at 80 y. Men 
who smoke show a greater bone loss at the trochanter. Female 
smokers have been shown to be at greater risk of hip fracture than 
nonsmokers, with the risk increasing in line with cigarette 
consumption.  
The level of risk declines on giving up smoking, but is not 
significantly reduced until 10 y after cessation. Smokers should be 
considered at greater risk of osteoporosis than non-smokers, and 
advised to stop, for this and other reasons. All the smokers 
10(12.19%) in our study were counseled to quit the smoking. 
In our study population, 54.87% were non-exercising, and the 
remaining 45.12% were exercising. However, a study of an 
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Australian population has shown that individuals with a sedentary 
adolescent lifestyle should be considered at higher risk of 
osteoporosis and thus the patients who were not exercising are 
counseled to do exercise to avoid worsening of the condition.  
Non-vegetarians 63(76.82%) were more in our study population 
than the vegetarian 16(19.51%). Bone mass and quality is mainly 
determined genetically, many other factors, including lifestyle and 
nutrition, also have an impact on bone health. It has been suggested 
that dietary protein intake may be a risk factor for osteoporosis, and 
high-protein diets are associated with increased bone loss. 
In our study, a patient treated with calcium has improved domains like 
leisure, social activity; a slight improvement was noticed in pain and 
mobility. A study by Ronald Hamdy et. al., showed that Calcium 
supplements appear to be effective in reducing bone loss in women 
late post menopause (>5 y post menopause), particularly in those with 
low habitual Calcium intake (<400 mg/d). In women early post 
menopause (<5 y post menopause) who are not vitamin D deficient, 
Calcium supplementation has little effect on bone mineral density [7]. 
The effect of calcium & physiotherapy showed improvement in 
specific domains like pain and mobility, it may be due to 
strengthening of the muscles and reducing the spasm around the 
joints, thereby relieves the pain and improves the mobility or by 
enhancing the bone mineralization which can modify involutional 
bone loss in women after menopause and thereby strengthening the 
bones and decrease the pain and improve the mobility [8]. While the 
other domains like jobs around the house, mental function, and 
general health perception showed slight improvement. 
Calcium and vitamin D3 showed significance improvement on 
activities of daily living and jobs around the house by decreasing the 
fall and preventing fractures which is similar to the earlier findings 
by Susan [9]. 
Among the three different modalities, calcium and physiotherapy 
proved to have a significant improvement in the total quality of life 
than calcium and its combination therapy with vitamin D3, which is 
similar to the earlier study done by Guido Schröder et al., (2012) [10]. 
CONCLUSION 
The prevalence of osteoporosis in the Nilgiris district was found to 
be 4.82%.  
Among the different domains of QUALEFFO-41questionnaire of 
osteoporotic international foundation (IOF), patients treated with 
calcium were effective in improving leisure, social activity. 
Calcium & physiotherapy was effective in improving mobility and pain. 
Calcium & Vitamin D3 group was effective in improving Physical 
function (activities of daily living). 
From this study, it can be concluded that calcium & physiotherapy may 
be helpful to improve the total quality of life in osteoporotic patients.  
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